In the first weeks of March 2020, the global pharmaceutical freight network unravelled faster than most logistics professionals had thought possible. Passenger aircraft, which had carried the bulk of time-sensitive medical cargo as belly freight for decades, were grounded across Europe, North America, and Asia. Port closures and border disinfection protocols added days to transit times. Spot airfreight rates in certain lanes increased by several hundred percent.